Polaris Group (TPE:6550) Debt-to-Equity : 0.28 (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Polaris Group Debt-to-Equity?

Polaris Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$67.45 Mil. Polaris Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$1,655.50 Mil. Polaris Group's Total Stockholders Equity for the quarter that ended in Sep. 2024 was NT$6,080.72 Mil. Polaris Group's debt to equity for the quarter that ended in Sep. 2024 was 0.28.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Polaris Group's Debt-to-Equity or its related term are showing as below:

TPE:6550' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.15 Max: 7.03
Current: 0.28

During the past 10 years, the highest Debt-to-Equity Ratio of Polaris Group was 7.03. The lowest was 0.04. And the median was 0.15.

TPE:6550's Debt-to-Equity is ranked worse than
62.66% of 1023 companies
in the Biotechnology industry
Industry Median: 0.14 vs TPE:6550: 0.28

Polaris Group Debt-to-Equity Historical Data

The historical data trend for Polaris Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris Group Debt-to-Equity Chart

Polaris Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.08

0.11

0.06

0.04

0.16

Polaris Group Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															0.12	0.16	0.17	0.26	0.28

Competitive Comparison of Polaris Group's Debt-to-Equity

For the Biotechnology subindustry, Polaris Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polaris Group's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Polaris Group's Debt-to-Equity falls into.

Polaris Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Polaris Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(746.437	+	451.595)	/	7366.027
	=	0.16

Polaris Group's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(67.453	+	1655.499)	/	6080.722
	=	0.28

Polaris Group (TPE:6550) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Polaris Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Polaris Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Polaris Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN

Website

https://www.polarispharma.com

Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines